| Chimeric antigen receptor-engineered T-cell therapy for liver cancer | |
| Zhang, Xue-Wen; Wang, Zhen-Xiao; Liu, Shui; Gong, Zhi-Wen; Chang-Yong, E.; Chen, Yang; Yang, Yong-Sheng | |
| 刊名 | HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
 |
| 2018 | |
| 卷号 | 17期号:4 |
| ISSN号 | 1499-3872 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3512148 |
| 专题 | 吉林大学白求恩第三医院 |
| 推荐引用方式 GB/T 7714 | Zhang, Xue-Wen,Wang, Zhen-Xiao,Liu, Shui,et al. Chimeric antigen receptor-engineered T-cell therapy for liver cancer[J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL,2018,17(4). |
| APA | Zhang, Xue-Wen.,Wang, Zhen-Xiao.,Liu, Shui.,Gong, Zhi-Wen.,Chang-Yong, E..,...&Yang, Yong-Sheng.(2018).Chimeric antigen receptor-engineered T-cell therapy for liver cancer.HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL,17(4). |
| MLA | Zhang, Xue-Wen,et al."Chimeric antigen receptor-engineered T-cell therapy for liver cancer".HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL 17.4(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论